Initial Safety Experience of Abciximab and Heparin for Acute Ischemic Stroke

This publication has 11 references indexed in Scilit:

• Catheter-Based Treatment for Patients With Acute Ischemic Stroke Ineligible for Intravenous Thrombolysis
  Stroke, 2004
• Abciximab Treatment for Obstructive Prosthetic Aortic and Mitral Valve Thrombosis in the Presence of Large Thrombi, Cardiogenic Shock, and Acute Evolving Embolic Stroke
  Echocardiography, 2004
• Platelet glycoprotein IIb/IIIa antagonists for acute ischemic stroke
  Neurology, 2001
• Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention.
  JAMA, 2001
• Safety of Intra-Arterial Thrombolysis in the Postoperative Period
  Stroke, 2001
• Abciximab in Acute Ischemic Stroke
  Stroke, 2000
• Intra-arterial Prourokinase for Acute Ischemic Stroke
  JAMA, 1999
• Restoration of Coronary Flow in Myocardial Infarction by Intravenous Chimeric 7E3 Antibody Without Exogenous Plasminogen Activators
  Circulation, 1997
• Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke
  Circulation, 1996
• The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram
  Annals of Internal Medicine, 1993